Neurone S.A. investment portfolio

Biocentis Limited develops genetically engineered insects and a genetic‑control technology platform to target harmful insect species that transmit diseases, damage crops, and threaten biodiversity, serving markets in public health, agriculture and environmental protection.

Neulabs acquires, builds and scales direct‑to‑consumer digital brands, launching new brands or purchasing existing ones that sell primarily online across Europe, and it also provides Amazon channel management and digital‑distribution consulting services for large traditional companies seeking to grow their online sales. Its target market includes D2C brands and established brands looking to expand their e‑commerce presence in European markets.